An unconventional EGFR-independent signal of EGF, the KITENIN/ErbB4–Dvl2–c-Jun axis, also mediates increased CRC cell invasiveness and is associated with acquired resistance to cetuximab [12, 13]. This evidence concerns the gene VANGL1 and colorectal carcinoma.